Latest News From The NAC: Spring 2022

Thalidomide Trust NAC member Rowland BarehamNAC Chair, Rowland Bareham, provides an update on actions and progress during the last quarter

As I started to write, I reflected that it’s April, meaning that the first quarter of 2022 has whizzed by – how time flies! Christmas didn’t seem that long ago.

So much has happened in the last quarter: we’ve had the Earlier, Great and Longer Report (see Graham’s article); the results of the Beneficiary Consultation for the Diageo Review, leading to the firming up of our ‘Asks’ for the review talks (for which I appreciate some of the messages of support and thanks); and NAC colleagues have been busy recruiting our new Communications Officer. Paul Randall started working with us on 19 April - "Welcome Paul"! More introductions in our summer edition.

Strategic plan

The NAC, together with Trust staff and trustees have also begun work on the Trust’s strategic plan for the next 5 years (1 October 2022 – 30 September 2027). We will be reporting on this as work continues over the year.

NAC Election

We’ve had the outcome of the NAC election process with fewer candidates than places. I thank those leaving the NAC, Maggie Boyd and Phil Williams, for all they’ve done. And I welcome on board David Alexander joining the NAC.

Since the conclusion of the NAC election process, Sue Gooding has decided to resign from the NAC from 19 May. I thank Sue also for all she has done.

Until next time, take care.

Read more from the NAC in the full Spring 2022 Newsletter (PDF)